Evidence map›Paper›PMID 35059205›Full record

ReviewIUCrJ2022

Using crystallography tools to improve vaccine formulations.

Márcia Carvalho de Abreu Fantini, Cristiano Luis Pinto Oliveira, José Luiz de Souza Lopes, Tereza da Silva Martins, Milena Apetito Akamatsu, Aryene Góes Trezena, Milene Tino-De- Franco, Viviane Fongaro Botosso, Osvaldo Augusto Brazil Esteves Sant'Anna, Nikolay Kardjilov and 2 more

Abstract readReview
In one paragraph

Review in IUCrJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Márcia Carvalho de Abreu FantiniPhysics Institute, University of São Paulo, Rua do Matão 1371, São Paulo, SP 05508-090, Brazil.ORCID https://orcid.org/0000-0001-6862-8716
Cristiano Luis Pinto OliveiraPhysics Institute, University of São Paulo, Rua do Matão 1371, São Paulo, SP 05508-090, Brazil.ORCID https://orcid.org/0000-0002-3426-6507
José Luiz de Souza LopesPhysics Institute, University of São Paulo, Rua do Matão 1371, São Paulo, SP 05508-090, Brazil.ORCID https://orcid.org/0000-0003-1281-0521
Tereza da Silva MartinsChemistry Department, Federal University of São Paulo, Rua São Nicolau, 210, 2o andar, Diadema, SP 09913-030, Brazil.
Milena Apetito AkamatsuBioindustrial Center, Butantan Institute, Avenida Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0002-8193-3448
Aryene Góes TrezenaImmunogenetic Laboratory, Butantan Institute, Avenida Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Milene Tino-De- FrancoImmunogenetic Laboratory, Butantan Institute, Avenida Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Viviane Fongaro BotossoVirology Laboratory, Butantan Institute, Avenida Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Osvaldo Augusto Brazil Esteves Sant'AnnaImmunochemistry Laboratory, Butantan Institute, Avenida Vital Brazil, 1500, São Paulo, SP 05503-900, Brazil.
Nikolay KardjilovHZB für Materialien und Energie, Helmholtz-Zentrum Berlin, Hahn-Meitner-Platz 1, 14109 Berlin, Germany.ORCID https://orcid.org/0000-0002-0980-1440
Martin Kjaerulf RasmussenNiels Bohr Institute, University of Copenhagen, Universitetsparken 5, Copenhagen 2100, Denmark.ORCID https://orcid.org/0000-0001-8719-7683
Heloísa Nunes BordalloNiels Bohr Institute, University of Copenhagen, Universitetsparken 5, Copenhagen 2100, Denmark.ORCID https://orcid.org/0000-0003-0750-0553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article summarizes developments attained in oral vaccine formulations based on the encapsulation of antigen proteins inside porous silica matrices. These vaccine vehicles show great efficacy in protecting the proteins from the harsh acidic stomach medium, allowing the Peyer's patches in the small intestine to be reached and consequently enhancing immunity. Focusing on the pioneering research conducted at the Butantan Institute in Brazil, the optimization of the antigen encapsulation yield is reported, as well as their distribution inside the meso- and macroporous network of the porous silica. As the development of vaccines requires proper inclusion of antigens in the antibody cells, X-ray crystallography is one of the most commonly used techniques to unveil the structure of antibody-combining sites with protein antigens. Thus structural characterization and modelling of pure antigen structures, showing different dimensions, as well as their complexes, such as silica with encapsulated hepatitis B virus-like particles and diphtheria anatoxin, were performed using small-angle X-ray scattering, X-ray absorption spectroscopy, X-ray phase contrast tomography, and neutron and X-ray imaging. By combining crystallography with dynamic light scattering and transmission electron microscopy, a clearer picture of the proposed vaccine complexes is shown. Additionally, the stability of the immunogenic complex at different pH values and temperatures was checked and the efficacy of the proposed oral immunogenic complex was demonstrated. The latter was obtained by comparing the antibodies in mice with variable high and low antibody responses.

Indexed as

imagingoral vaccinesporous silicaSAXSXAS

Identifiers

PMID35059205
PMCPMC8733884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.